{"id":15344,"date":"2020-03-02T07:30:05","date_gmt":"2020-03-02T12:30:05","guid":{"rendered":"https:\/\/medicarereport.org\/?p=15344"},"modified":"2020-03-02T07:30:05","modified_gmt":"2020-03-02T12:30:05","slug":"fda-approves-first-generic-version-of-drug-that-made-martin-shkreli-infamous","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=15344","title":{"rendered":"FDA approves first generic version of drug that made Martin Shkreli infamous"},"content":{"rendered":"<p>(By Maia Anderson for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>The FDA approved Feb. 28 the first generic version of Daraprim, the lifesaving drug for which Martin Shkreli became infamous by raising the price by 4,000 percent overnight.\u00a0 Continue reading article<a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/fda-approves-first-generic-version-of-drug-that-made-martin-shkreli-infamous.html\"> here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-7881\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo-300x97.jpg\" alt=\"\" width=\"300\" height=\"97\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo-300x97.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo.jpg 322w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Maia Anderson for Becker&#8217;s Hospital Review) The FDA approved Feb. 28 the first generic version of Daraprim, the lifesaving<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,15],"tags":[],"class_list":["post-15344","post","type-post","status-publish","format-standard","hentry","category-fda","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15344"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15344\/revisions"}],"predecessor-version":[{"id":15345,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/15344\/revisions\/15345"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}